UNITED THERAPEUTICS Corp — Director's Dealing 2021

Mar 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2018-03-15

Reporting Person: ROTHBLATT MARTINE A (Director, Chairman & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-15	Stock Options	$111.00	A	285103	Acquired	2018-03-15	Common Stock (285103)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	140	Direct
Common Stock	166	Indirect
Common Stock	662366	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$113.08	2023-12-31	Common Stock (1000000)	1000000	Direct
Stock Options	$129.49	2024-12-31	Common Stock (723869)	723869	Direct
Stock Options	$120.26	2026-03-15	Common Stock (294000)	294000	Direct

Footnotes

F1: These performance-based stock options were initially awarded on March 15, 2018, subject to a three-year performance condition tied to average cash profit margin during 2018-2020, which was determined on February 24, 2021. Number of stock options reported represents the number of options earned based on performance.

F2: This stock option was transferred from a trust beneficially owned by the reporting person on March 1, 2021.